ELITE PHARMACEUTICALS INC /NV/ - 8-K Filing

Elite Pharmaceuticals reports Q2 fiscal year 2027 revenue of $40.1 million, up 10.4% YoY. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 22:20 UTC

Tickers: $ELTP

Read the full article at SEC EDGAR

Part of the story ELITE PHARMACEUTICALS INC /NV/ - 10-Q Filing (3 articles)

More Regulatory news

Super Micro Computer, Inc. - 4 Filing SEC EDGAR · November 12, 2026, 22:39 UTC
BT Brands, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:32 UTC
MICROVISION, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 22:31 UTC
Fermi Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:29 UTC
Freenome, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:29 UTC
MEXCO ENERGY CORP - 8-K Filing SEC EDGAR · November 12, 2026, 22:28 UTC
SHF Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 22:28 UTC
SILVER BOW MINING CORP. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:27 UTC
HOST HOTELS & RESORTS, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 22:27 UTC
LGL GROUP INC - 10-Q Filing SEC EDGAR · November 12, 2026, 22:27 UTC